S04.1 Resistance-guided therapy for m. genitalium: impact of diagnostic resistance assays on practice and policy | Sexually Transmitted Infections

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Symposia Presentations

S04 – THE IMPACT OF ADVANCES IN DIAGNOSTIC TECHNOLOGY ON POLICY, PROGRAM AND PRACTICE (ISSTDR SPECIAL SYMPOSIUM)

Monday, July 15, 2019 10:45 AM – 12:15 PM

S04.1 Resistance-guided therapy for m. genitalium: impact of diagnostic resistance assays on practice and policy

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Bradshaw C

S04.1 Resistance-guided therapy for m. genitalium: impact of diagnostic resistance assays on practice and policy

Sexually Transmitted Infections 2019;95:A11.